about
Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer preventionCatalytic autoantibodies in clinical autoimmunity and modern medicine.First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)Morphofunctional and signaling molecules overlap of the pineal gland and thymus: role and significance in aging.Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation.β1 integrin as the integrating component in cell-cell cooperation for maintenance of lens transparency.Acinar B-cells in pancreas in insulin-dependent diabetic patients. The right to existA possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus
P50
Q34323757-93A09A54-22E0-4E69-B1E5-8C37A7286247Q36388753-F29525E2-895E-46D5-B5C6-FC321B040C35Q36510620-EC0F901F-40CE-4D2C-BEA2-6DB70028D00AQ36759766-1DBAED9F-E305-4063-8131-32373B21CC39Q39948155-387D3945-F805-4F7B-AA12-FC826CD50861Q42516458-5C2D1AC0-C085-4223-AB62-B53FDA970663Q45504129-12BD05AA-948F-4373-AC4B-AC8045344E8AQ72834499-2122D292-4A44-42EB-AA4E-958E745AFDD8Q82612167-88689062-E364-42EA-A8D9-6E2C927D29E3
P50
description
researcher
@en
name
Mikhail A. Paltsev
@en
Paltsev M
@nl
type
label
Mikhail A. Paltsev
@en
Paltsev M
@nl
altLabel
Paltsev M
@en
prefLabel
Mikhail A. Paltsev
@en
Paltsev M
@nl
P106
P31
P496
0000-0002-5737-5706